Human Repeat Insult Patch Test to Evaluate Personal Lubricants
Not Applicable
Completed
- Conditions
- EdemaErythema
- Interventions
- Device: "Chameleon" Personal Lubricant
- Registration Number
- NCT02737631
- Lead Sponsor
- Church & Dwight Company, Inc.
- Brief Summary
The purpose of this test is to evaluate the sensitizing potential of a personal lubricant, as a result of repeated occlusive patch. The intervention will be applied for a total of 9 induction applications, followed by an approximately 2 week rest period, then followed by a 24-72 hour Challenge applications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 222
Inclusion Criteria
- good health as determined from screener
- signed and dated informed consent
- signed and dated HIPAA Form
Exclusion Criteria
- subjects on test at any other research laboratory or clinic
- known allergy or sensitivity to cosmetics and toiletries, including sunscreens, adhesives and/or topical drugs
- pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study
- pre-existing other medical conditions (e.g. adult asthma, diabetes).
- treatment with antibiotics, antihistamines or corticosteroids within two weeks prior to initiation of the test
- chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)
- known pregnant or nursing women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Healthy subject "Chameleon" Personal Lubricant Healthy subjects exposed to "Chameleon" personal lubricant via occlusive patch
- Primary Outcome Measures
Name Time Method Number of Patients That Showed Sensitization Reaction to the Test Material at Challenge 24, 48 and 72 hours after patch application
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Harrison Research Laboratories, Inc.
🇺🇸Union, New Jersey, United States